Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDï¾™ single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneï¾’s single-dose intranasal vaccine…
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
Novavax identified Coronavirus vaccine candidate; accelerated initiation of first-in-human trial to mid-May
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
The FDA announced publication of ARGOS SARS-CoV-2 reference grade sequence data
On Apr. 2, 2020, the FDAï¾—in collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent will provide molecule-to-market contract development…
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The Rockefeller University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neuroscience Discovery Institute at The Johns Hopkins University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
OriGene Technologies aquired Blue Heron Biotechnology
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
Researchers described successful construction of the first self-replicating, synthetic bacterial cell
On May 20, 2010, researchers at the J. Craig Venter Institute in Maryland published results describing the successful…
Hanger corporate headquarters was relocated from Bethesda, MD to Austin, TX
In 2010, Hanger announced that it will relocate it’s corporate headquarters was relocated from Bethesda, MD to Austin,…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center received NCI designation
In 2008, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCC) received NCI designation, a…
Biotechnology | Chemical | Diagnostics | Environmental | Life Science News | Marine Science | Medical Device | Non-Profit Research
Grant from Gordon and Betty Moore Foundation to Calit2 and the Venter Institute established CAMERA
On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute for Brain Science at Columbia University Medical Center
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
Sidney Kimmel gave $150 million to Hopkins for cancer research and patient
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
Georgetown University Hospital became part of MedStar Health
In 2000, the Georgetown University Hospital became part of MedStar Health, a not-for-profit network of seven hospitals in…
Trubion Pharmaceutical was founded
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…